Publications by authors named "Despoina Mparmparoussi"
Lenalidomide and dexamethasone for the treatment of refractory/relapsed multiple myeloma: dosing of lenalidomide according to renal function and effect on renal impairment.
Meletios A Dimopoulos Dimitrios Christoulas Maria Roussou Efstathios Kastritis Magdalini Migkou Despoina Mparmparoussi
Eur J Haematol
July 2010
Objectives: Lenalidomide and dexamethasone (LenDex) is an active regimen for relapsed/refractory multiple myeloma (MM). However, there is limited data for the effect of LenDex on renal impairment (RI) and on renal reversibility.
Patients & Methods: Fifty consecutive patients with relapsed/refractory MM received LenDex in 28-d cycles.